Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication January 28, 2013
- Accepted for publication May 2, 2013
- Published online October 1, 2013.
Article Versions
- previous version (August 8, 2013 - 06:01).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Mattias Sandström1,2,
- Irina Velikyan1,3,
- Ulrike Garske-Román1,3,
- Jens Sörensen1,3,
- Barbro Eriksson4,
- Dan Granberg4,
- Hans Lundqvist5,
- Anders Sundin6 and
- Mark Lubberink1,2
- 1Nuclear Medicine and PET, Uppsala University, Uppsala, Sweden
- 2Medical Physics, Uppsala University Hospital, Uppsala, Sweden
- 3Molecular Imaging, Uppsala University Hospital, Uppsala, Sweden
- 4Endocrine Oncology, Uppsala University, Uppsala, Sweden
- 5Biomedical Radiation Sciences, Uppsala University, Uppsala, Sweden; and
- 6Radiology, Karolinska University Hospital, Stockholm, Sweden
- For correspondence or reprints contact: Mark Lubberink, PET Centre, Uppsala University Hospital, 751 85 Uppsala, Sweden. E-mail: mark.lubberink{at}akademiska.se
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Safety, Biodistribution, and Radiation Dosimetry of the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors
- Biodistribution, Dosimetry, and Pharmacokinetics of 68Ga-CBP8: A Type I Collagen-Targeted PET Probe
- Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin {alpha}v{beta}3 for Prognostication in Patients with Neuroendocrine Neoplasms
- FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
- Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
- Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE
- PET-Based Human Dosimetry of 68Ga-NODAGA-Exendin-4, a Tracer for {beta}-Cell Imaging
- 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
- Comparative Dosimetry for 68Ga-DOTATATE: Impact of Using Updated ICRP Phantoms, S Values, and Tissue-Weighting Factors
- Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
- Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
- Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast
- Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging
- Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions
- Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
- Radiation Dosimetry of the Fibrin-Binding Probe 64Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats
- Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy
- 64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
- Biodistribution and Radiation Dosimetry for the Chemokine Receptor CXCR4-Targeting Probe 68Ga-Pentixafor
- Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification